Overview
Cervical Cancer prevention comprises the strategies used to reduce the incidence of and mortality from cancer of the cervix, the lower portion of the uterus, the great majority of which is caused by persistent infection with high-risk human papillomavirus (HPV). Prevention operates on two complementary levels. Primary prevention targets the causal infection itself through HPV vaccination and reduction of transmission, supported by understanding of the role of human papillomavirus in virus-induced carcinogenesis and of the molecular pathways, such as PI3K/mTOR/AKT signaling, activated in cervical tumors. Secondary prevention relies on screening to detect precancerous changes before invasive disease develops, using cytology-based Pap testing and HPV testing so that abnormalities can be treated early. A substantial body of work addresses the determinants of screening uptake and the barriers that limit it, examining awareness of Cervical Cancer screening among women of childbearing age, the proportion of women who actually undergo testing in referral and university hospital settings, and uptake among underserved populations including rural communities and refugee women. These studies highlight knowledge, access, and health-system factors as critical to effective programs. Together, vaccination, organized screening, timely treatment of precancerous lesions, and attention to behavioral and structural barriers form the foundation of Cervical Cancer prevention.
Research published in this journal
8 peer-reviewed articles, ranked by relevance. Each links to its DOI.
One Out of Five Women Practiced Cervical Cancer Screening in Felege Hiwot Referral Hospital, Amhara, North West Ethiopia
Awareness of Cervical Cancer Screening test Among Women of Child Bearing age in the Rural Area of Awo-Omamma, Imo State, Nigeria.
Review: The Role of Human Papillomavirus in Virus-Induced Carcinogenesis
Uptake of Cervical Cancer Screening Among Female Staff at the University College Hospital, Ibadan
Cervical Cancer with The Active And Stable PI3K/MTOR/AKT Pathway In Azerbaijan Patients
Consciousness Energy Healing Treatment: Impact on the Physicochemical and Thermal Characteristics of Folic Acid
How this research is being cited
The 8 articles above have been cited 2 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2019 · Drug Development and Industrial Pharmacy
-
2019 · Drug Development and Industrial Pharmacy
A sample of recent works citing this journal's research on Cervical Cancer Prevention, linking to each citing work.